Developing collaborative solutions to prepare for future dementia treatments.
The Dementia Access Taskforce was launched in 2018, following analysis that showed future dementia treatments could have a significant impact on our health system.
Our areas of work:
Importance of early and accurate diagnosis
We are working to understand current public and health professional perceptions on diagnosis of Alzheimer’s disease. This will inform approaches for next steps in increasing public knowledge and supporting clinical education and development.
Our report, Detecting and diagnosing Alzheimer’s disease, marks the first piece of this work. Published in December 2019, it found people had a strong appetite to find out if they would develop Alzheimer’s. However, most would want tests to be accurate and to give certainty about disease progression.
Value and affordability of dementia treatments
We are exploring innovative pricing models and how the value of future Alzheimer’s disease treatments is assessed to ensure these treatments reach people quickly. To do this, we are considering cost to the health system, what patients want from treatments, and how to measure the benefit of treatments.
Introducing new treatments and impact on the health system
Working with the NHS and clinicians, we are assessing current barriers and opportunities to advanced diagnostic tools. We are also working to better understand how dementia is diagnosed, focusing on NHS workforce, infrastructure, and Memory Assessment Services needs.